A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption. This analysis uses a transport model and human permeability results for estimating in vivo drug absorption to illustrate the primary importance of solubility and permeability on drug absorption. The fundamental parameters which define oral drug absorption in humans resulting from this analysis are discussed and used as a basis for this classification scheme. These Biopharmaceutic Drug Classes are defined as: Case 1. High solubility-high permeability drugs, Case 2. Low solubility-high permeability drugs, Case 3. High solubility-low permeability drugs, and Case 4. Low solubility-low permeability drugs. Based on this classification scheme, suggestions are made for setting standards for in vitro drug dissolution testing methodology which will correlate with the in vivo process. This methodology must be based on the physiological and physical chemical properties controlling drug absorption. This analysis points out conditions under which no in vitro-in vivo correlation may be expected e.g. rapidly dissolving low permeability drugs. Furthermore, it is suggested for example that for very rapidly dissolving high solubility drugs, e.g. 85% dissolution in less than 15 minutes, a simple one point dis…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Gastroparesis caused by non-pharmacologic etiologies is indeed known to affect drug absorption [6, 7].”
From Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review (2024) · cites this paper as [6]
In the citing paper
“Application of the BCS in waiving BA/BE requirements is based on premises that if (1) two immediate-release (IR) drug formulations/products behave as oral solutions within the GI tract due to high solubility and rapid dissolution, (ii) no precipitation occurs in the GI tract once the API is dissolved, and (iii) the two IR formulations have the same in vivo dissolution profile under all intestinal”
From BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements (2016) · cites this paper as [4]
In the citing paper
“The Biopharmaceutics Classification System (BCS), based on aqueous solubility and intestinal permeability, has enjoyed wide use since 1995 as a mechanism for waiving in vivo bioavailability and bioequivalence studies.”
From BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements (2016) · cites this paper as [4]
Citations
Cites
Diffusion, mass transfer in fluid systems
(1997) · Choice Reviews Online · doi:10.5860/choice.35-0927 · Cited by 4,930
Transit of pharmaceutical dosage forms through the small intestine.
Davis, S. S., Hardy, J. G., & Fara, J. W. (1986) · Gut · doi:10.1136/gut.27.8.886 · Cited by 853
The effect of particle size distribution on dissolution rate and oral absorption
HINTZ, R., & JOHNSON, K. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90069-0 · Cited by 331
Amidon, G. L., Sinko, P. J., & Fleisher, D. (1988) · Pharmaceutical Research · doi:10.1023/a:1015927004752 · Cited by 300
Self-citationOh, D.-M., Curl, R. L., & Amidon, G. L. (1993) · Pharmaceutical Research · doi:10.1023/a:1018947113238 · Cited by 253
Self-citationRegional Rectal Perfusion: A New in Vivo Approach to Study Rectal Drug Absorption in Man
Lennernäs, H., Fagerholm, U., Raab, Y., Gerdin, B., & Hällgren, R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016216905197 · Cited by 219
Self-citationOberle, R. L., & Amidon, G. L. (1987) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061761 · Cited by 208
Self-citationRegional Jejunal Perfusion, a New in Vivo Approach to Study Oral Drug Absorption in Man
Lennernäs, H., Ahrenstedt, Ö., Hällgren, R., Knutson, L., Ryde, M., & Paalzow, L. K. (1992) · Pharmaceutical Research · doi:10.1023/a:1015888813741 · Cited by 202
Self-citationPredicting Fraction Dose Absorbed in Humans Using a Macroscopic Mass Balance Approach
Sinko, P. J., Leesman, G. D., & Amidon, G. L. (1991) · Pharmaceutical Research · doi:10.1023/a:1015892621261 · Cited by 178
Self-citationIn Vitro Dissolution Profile of Water-Insoluble Drug Dosage Forms in the Presence of Surfactants
Shah, V. P., Konecny, J. J., Everett, R. L., McCullough, B., Noorizadeh, A. C., & Skelly, J. P. (1989) · Pharmaceutical Research · doi:10.1023/a:1015909716312 · Cited by 162
Self-citation
Research works printed but not linked: 5
- E.M. Topp, Physiological Flow Models for Intestinal Absorption and Plasma Kinetics of Aspirin, Thesis, The University of Michigan (1986).
- G.D. Leesman, P.J. Sinko, and G.L. Amidon, Simulation of Oral Drug Absorption: Gastric Emptying and Gastrointestinal Motility, in: Pharmacokinetics, P.W. Welling and F.L.S. Tse, Editors, Marcel Dekker, Inc., (NY) 1988, Ch 6, p 267.
- V.G. Levich, Physico-Chemical Hydrodynamics, Prentice-Hall, Englewood Cliffs, NJ (1962).
- H.M. Abdou, Dissolution, Bioavailability, & Bioequivalence, A. Gennaro, B. Migdalof, G.L. Hassert and T. Medwick (Eds), Mack Publishing Co., Easton PA (1989).
- The Merck Index, Tenth Edition, Merck & Co., Inc., Rahway, NJ (1983).
Cited by
Items 101–200 of 1,018
Pandi, P., Bulusu, R., Kommineni, N., Khan, W., & Singh, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119560 · Cited by 391
Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs
Liu, Y., Liang, Y., Yuhong, J., Xin, P., Han, J. L., Du, Y., Yu, X., Zhu, R., Zhang, M., Chen, W., et al. (2024) · Drug Design, Development and Therapy · doi:10.2147/dddt.s447496 · Cited by 365
“19,20 Moreover, the theoretical framework of BCS enables formulation scientists to develop drug formulations based on the physicochemical and biopharmaceutical properties of the drug, rather than solely relying on experience.”
BackgroundDesign and optimization of a new self-nanoemulsifying drug delivery system
Wang, L., Dong, J., Chen, J., Eastoe, J., & Li, X. (2009) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2008.10.077 · Cited by 402
Ionic Liquids as Active Pharmaceutical Ingredients
Ferraz, R., Branco, L. C., Prudêncio, C., Noronha, J. P., & Petrovski, Ž. (2011) · ChemMedChem · doi:10.1002/cmdc.201100082 · Cited by 379
Intestinal permeation enhancers for oral peptide delivery
Maher, S., Mrsny, R. J., & Brayden, D. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.005 · Cited by 381
“Intestinal epithelial permeability of peptides is predicted to be low based on metrics outlined in Lipin si “Rule of 5” [47], the BCS [48], the Biopharmaceutics Drug”
BackgroundInfluentialIn vitro assessment of oral lipid based formulations
Porter, C. J. H., & Charman, W. N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00182-x · Cited by 389
Cao, X., Gibbs, S. T., Fang, L., Miller, H. A., Landowski, C. P., Shin, H.-C., Lennernas, H., Zhong, Y., Amidon, G. L., Yu, L. X., et al. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9041-2 · Cited by 388
“Oral drug absorption (Fa) is determined by two fundamental parameters: the drug’s solubility and its gastrointestinal permeability (3).”
BackgroundSelf-citationMaterials chemistry and the futurist eco-friendly applications of nanocellulose: Status and prospect
Mishra, R. K., Sabu, A., & Tiwari, S. K. (2018) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2018.02.005 · Cited by 382
Ahuja, N., Katare, O. P., & Singh, B. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.07.007 · Cited by 388
“Poorly water-soluble drugs are associated with slow drug absorption leading eventually to inadequate and variable bioavailability [1,2].”
BackgroundIn vitro models for the prediction of in vivo performance of oral dosage forms
Kostewicz, E. S., Abrahamsson, B., Brewster, M., Brouwers, J., Butler, J., Carlert, S., Dickinson, P. A., Dressman, J., Holm, R., Klein, S., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.024 · Cited by 373
“It provided the platform to use in vitro data generated with the paddle/basket apparatus rather than in vivo human studies for establishing bioequivalence of BCS class I compounds (Amidon et al., 1995; Food and Drug Administration, 2009)”
MethodGuzmán, H. R., Tawa, M., Zhang, Z., Ratanabanangkoon, P., Shaw, P., Gardner, C. R., Chen, H., Moreau, J., Almarsson, Ö., & Remenar, J. F. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20906 · Cited by 381
Cyclodextrin-based nanosponges as drug carriers
Trotta, F., Zanetti, M., & Cavalli, R. (2012) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.8.235 · Cited by 367
Boyd, B. J., Bergström, C. A. S., Vinarov, Z., Kuentz, M., Brouwers, J., Augustijns, P., Brandl, M., Bernkop-Schnürch, A., Shrestha, N., Préat, V., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.104967 · Cited by 367
BCS class IV drugs: Highly notorious candidates for formulation development
Ghadi, R., & Dand, N. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.014 · Cited by 361
“Based on the BCS, drugs are classified into four categories according to their solubility and permeability properties as follows; high solubility–high permeability (class I); low solubility–high permeability (class II); high solubility–low permeability (class III); and low solubility–low permeability (class IV) [3].”
BackgroundTsume, Y., Mudie, D. M., Langguth, P., Amidon, G. E., & Amidon, G. L. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.01.009 · Cited by 350
“The Biopharmaceutics Classification System (BCS) and the corresponding guidance issued by the FDA categorize drug substances into 4 groups based on aqueous solubility and intestinal membrane permeability (Amidon et al., 1995).”
BackgroundMethodInfluentialSelf-citationFood, gastrointestinal pH, and models of oral drug absorption
Abuhelwa, A. Y., Williams, D. B., Upton, R. N., & Foster, D. J. R. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.11.034 · Cited by 349
“In another example, GastroPlusTM has been used to establish IVIVC of drugs by simulating the in vivo absorption profile using biorelevant in vitro dissolution data [162,163].”
BackgroundInfluentialMachine learning directed drug formulation development
Bannigan, P., Aldeghi, M., Bao, Z., Häse, F., Aspuru-Guzik, A., & Allen, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.016 · Cited by 335
Mechanisms of increased bioavailability through amorphous solid dispersions: a review
Schittny, A., Huwyler, J., & Puchkov, M. (2020) · Drug Delivery · doi:10.1080/10717544.2019.1704940 · Cited by 343
“Famous examples of such predictive possibilities are the biopharmaceutical classification system (Amidon et al., 1995) or Lipinski’s ‘Rule of Five’ (Fischer & Breitenbach, 2013).”
BackgroundBenet, L. Z. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23359 · Cited by 342
Electrospun amorphous solid dispersions of poorly water-soluble drugs: A review
Yu, D.-G., Li, J.-J., Williams, G. R., & Zhao, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.016 · Cited by 341
“Electrospun nanofiber-based ASDs, particularly the second, third and fourth-generation products, are usually used to provide fast drug dissolution profiles, particularly for those APIs belonging to BCS Class II [202].”
BackgroundDahan, A., & Hoffman, A. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.021 · Cited by 341
Lipid-based formulations for oral administration of poorly water-soluble drugs
Mu, H., Holm, R., & Müllertz, A. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.054 · Cited by 328
“However, it seems that a high permeability is maintained for most of these compounds, rendering them class II drugs in the Biopharmaceutics Classification System (BCS) (Amidon et al., 1995; Lipinski 2000; Lipinski et al., 1997; Yu et al., 2002).”
BackgroundDima, C., Assadpour, E., Dima, S., & Jafari, S. M. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12623 · Cited by 304
Intestinal drug transporters: An overview
Estudante, M., Morais, J. G., Soveral, G., & Benet, L. Z. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.042 · Cited by 330
High throughput physicochemical profiling for drug discovery
Kerns, E. H. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1134 · Cited by 343
Yu, L. X., Lipka, E., Crison, J. R., & Amidon, G. L. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00009-9 · Cited by 335
Self-citationPharmaceutical cocrystals: from serendipity to design to application
Kavanagh, O. N., Croker, D. M., Walker, G. M., & Zaworotko, M. J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.023 · Cited by 323
Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)
Varma, M. V., Steyn, S. J., Allerton, C., & El-Kattan, A. F. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1749-4 · Cited by 334
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2010) · Nanomedicine · doi:10.2217/nnm.09.110 · Cited by 324
Caco-2 monolayers in experimental and theoretical predictions of drug transport
Artursson, P., Palm, K., & Luthman, K. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00415-2 · Cited by 326
Sakagami, M. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.012 · Cited by 331
Son, G.-H., Lee, B.-J., & Cho, C.-W. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0320-1 · Cited by 320
Development of a new permeability assay using low‐efflux MDCKII cells
Di, L., Whitney‐Pickett, C., Umland, J. P., Zhang, H., Zhang, X., Gebhard, D. F., Lai, Y., Federico, J. J., Davidson, R. E., Smith, R., et al. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22674 · Cited by 313
McClements, D. J., Li, F., & Xiao, H. (2015) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-032814-014043 · Cited by 315
Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery
Jiao, J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.002 · Cited by 314
Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol
Chimento, A., De Amicis, F., Sirianni, R., Sinicropi, M. S., Puoci, F., Casaburi, I., Saturnino, C., & Pezzi, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061381 · Cited by 310
“[55], inserts RSV in the second class of drugs characterized by low water solubility (~30 mg/L) and high intestinal membrane permeability [55,56].”
BackgroundNanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
Fonseca-Santos, B., Chorilli, M., & Palmira Daflon Gremião, M. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87148 · Cited by 308
“Nanotechnology-based drug delivery systems Treatment options are limited mainly due to the inability of drugs to cross the blood–brain barrier (BBB) or their poor solubilities by oral route.(130,131) Many strategies have been developed to overcome the BBB, such as drug delivery systems, liposomes, polymeric and solid…”
In vitro - in vivo correlation: from theory to applications.
Emami, J. (2006) · PubMed · Cited by 323
Amorphous Drug Delivery Systems: Molecular Aspects, Design, and Performance
Kaushal, A. M., Gupta, P., & Bansal, A. K. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i3.10 · Cited by 312
Abdulhussain, R., Adebisi, A., Conway, B. R., & Asare-Addo, K. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105156 · Cited by 289
Paulekuhn, G. S., Dressman, J. B., & Saal, C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701032y · Cited by 304
Dahan, A., & Miller, J. M. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9337-6 · Cited by 298
“(4) revealed that the fundamental key parameters controlling oral drug ab-”
Recent advances of discrete coordination complexes and coordination polymers in drug delivery
Ma, Z., & Moulton, B. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.01.031 · Cited by 310
Zhang, X., Xing, H., Zhao, Y., & Ma, Z. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030074 · Cited by 285
“In the 1990s; the biopharmaceutical classification system (BCS) was introduced to characterize various drugs according to their solubility and permeability [1].”
BackgroundIntestinal permeability and its relevance for absorption and elimination
Lennernäs, H. (2007) · Xenobiotica · doi:10.1080/00498250701704819 · Cited by 304
“The Peff for hydrochlorotiazide, atenolol, furosemide and cimetidine, all of which are classified as lowpermeability drugs according to the BCS, decreased in the ileum in comparison with the jejunum (Lennernas 1998).”
BackgroundMethodInfluentialSelf-citationO'Driscoll, C. M., & Griffin, B. T. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.012 · Cited by 296
Probing the Probes: Fitness Factors For Small Molecule Tools
Workman, P., & Collins, I. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.05.013 · Cited by 299
Prediction of ADMET Properties
Norinder, U., & Bergström, C. A. S. (2006) · ChemMedChem · doi:10.1002/cmdc.200600155 · Cited by 285
Hydrotalcite-like compounds: Versatile layered hosts of molecular anions with biological activity
Costantino, U., Ambrogi, V., Nocchetti, M., & Perioli, L. (2008) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2007.02.005 · Cited by 298
Müllertz, A., Ogbonna, A., Ren, S., & Rades, T. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01107.x · Cited by 295
Foundations of gastrointestinal-based drug delivery and future developments
Chu, J. N., & Traverso, G. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00539-w · Cited by 289
Yazdanian, M., Briggs, K., Jankovsky, C., & Hawi, A. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016242.48642.71 · Cited by 290
“The Biopharmaceutical Classification System (BCS) is a scientific approach for classifying compounds based on solubility as related to dose and permeability of drug substance combined with the dissolution properties of the drug product (1).”
BackgroundInfluentialHan, H.-K., de Vrueh, R. L. A., Rhie, J. K., Covitz, K.-M. Y., Smith, P. L., Lee, C.-P., Oh, D.-M., Sadee, W., & Amidon1, G. L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011919319810 · Cited by 297
Self-citationEffects of renal failure on drug transport and metabolism
Sun, H., Frassetto, L., & Benet, L. Z. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.010 · Cited by 290
Role of Cyclodextrins in Improving Oral Drug Delivery
Loftsson, T., Brewster, M. E., & M??sson, M. (2004) · American Journal of Drug Delivery · doi:10.2165/00137696-200402040-00006 · Cited by 287
Gastrointestinal absorption of drugs: methods and studies
Barthe, L., Woodley, J., & Houin, G. (1999) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.1999.tb00334.x · Cited by 290
A dynamic in vitro lipolysis model
Zangenberg, N. H., Müllertz, A., Kristensen, H. G., & Hovgaard, L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00169-5 · Cited by 287
Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs
Whitty, A., Zhong, M., Viarengo, L., Beglov, D., Hall, D. R., & Vajda, S. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.005 · Cited by 285
Caco-2 monolayers in experimental and theoretical predictions of drug transport
Artursson, P., Palm, K., & Luthman, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.005 · Cited by 279
Maleki, A., Kettiger, H., Schoubben, A., Rosenholm, J. M., Ambrogi, V., & Hamidi, M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.047 · Cited by 281
“In order to find the best solutions for the oral bioavailability concerns, the BCS classifies drugs intended for oral administration into 4 different groups based on the aqueous solubility/dissolution as well as the intestinal epithelium permeability [4].”
BackgroundDissolution Testing for Generic Drugs: An FDA Perspective
Anand, O., Yu, L. X., Conner, D. P., & Davit, B. M. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9272-y · Cited by 274
“It is well-established that these three factors govern the rate and extent of drug absorption from IR solid oral dosage forms (11,12).”
BackgroundSanphui, P., Devi, V. K., Clara, D., Malviya, N., Ganguly, S., & Desiraju, G. R. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00020 · Cited by 282
A proposal for a drug product Manufacturing Classification System (MCS) for oral solid dosage forms
Leane, M., Pitt, K., Reynolds, G., & The Manufacturing Classification System (MCS) Working Group (2015) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2014.954728 · Cited by 277
“category incorporating other technologies, form the basis of the MCS as follows: (1) Direct Compression (DC)”
BackgroundDuarte, A. R. C., Ferreira, A. S. D., Barreiros, S., Cabrita, E., Reis, R. L., & Paiva, A. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.02.003 · Cited by 268
Solid form screening – A review
AALTONEN, J., ALLESO, M., MIRZA, S., KORADIA, V, GORDON, K., & RANTANEN, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.07.014 · Cited by 276
Walter, E., Janich, S., Roessler, B. J., Hilfinger, J. M., & Amidon, G. L. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960110x · Cited by 273
Self-citationYáñez, J. A., Remsberg, C. M., Sayre, C. L., Forrest, M. L., & Davies, N. M. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.19 · Cited by 279
Lennernäs, H., Palm, K., Fagerholm, U., & Artursson, P. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04204-0 · Cited by 274
Self-citationLagorce, D., Douguet, D., Miteva, M. A., & Villoutreix, B. O. (2017) · Scientific Reports · doi:10.1038/srep46277 · Cited by 266
“The BDDCS is a modification of the Biopharmaceutics Classification System (BCS) proposed by Amidon et al. 82 that is based on the experimentally determined permeability and solubility characteristics of a drug compound.”
MethodAzman, M., Sabri, A. H., Anjani, Q. K., Mustaffa, M. F., & Hamid, K. A. (2022) · Pharmaceuticals · doi:10.3390/ph15080975 · Cited by 250
Speybroeck, M. V., Barillaro, V., Thi, T. D., Mellaerts, R., Martens, J., Humbeeck, J. V., Vermant, J., Annaert, P., Den Mooter, G. V., & Augustijns, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21638 · Cited by 270
Recent Developments in the Crystallization Process: Toward the Pharmaceutical Industry
Gao, Z., Rohani, S., Gong, J., & Wang, J. (2017) · Engineering · doi:10.1016/j.eng.2017.03.022 · Cited by 260
“[51], divided into four classes of solubility.”
Pharmaceutical product development: A quality by design approach
Ali, J., Pramod, K., Tahir, M., Charoo, N., & Ansari, S. (2016) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.187350 · Cited by 249
Peeters, J., Neeskens, P., Tollenaere, J. P., Van Remoortere, P., & Brewster, M. E. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10126 · Cited by 272
Persson, E. M., Gustafsson, A.-S., Carlsson, A. S., Nilsson, R. G., Knutson, L., Forsell, P., Hanisch, G., Lennernäs, H., & Abrahamsson, B. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8192-x · Cited by 266
“These are all low solubility drugs according to the biopharmaceutical classification system (BCS) (32).”
BackgroundInfluentialSelf-citationJo, K., Cho, J. M., Lee, H., Kim, E. K., Kim, H. C., Kim, H., & Lee, J. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics11010001 · Cited by 266
“The hydrophilic polymers not only carry the dispersed drugs but also assist the formation of an amorphous state of the drugs, leading to an increase in the absorption of the drugs [17,18].”
BackgroundDahlgren, D., & Lennernäs, H. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11080411 · Cited by 255
“The BCS can also be used to predict in vivo drug absorption based on in vitro drug dissolution data [6].”
BackgroundMethodSelf-citationEarly pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs
Bergström, C. A. S., Holm, R., Jørgensen, S. A., Andersson, S. B. E., Artursson, P., Beato, S., Borde, A., Box, K., Brewster, M., Dressman, J., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.015 · Cited by 257
Miller, J. M., Beig, A., Carr, R. A., Spence, J. K., & Dahan, A. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300104s · Cited by 256
Sustained release of lidocaine from Poloxamer 407 gels
Ricci, E. J., Lunardi, L. O., Nanclares, D. M. A., & Marchetti, J. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.09.028 · Cited by 261
Membrane Transport of Drugs in Different Regions of the Intestinal Tract of the Rat
Ungell, A.-L., Nylander, S., Bergstrand, S., Sjöberg, Å., & Lennernäs, H. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970218s · Cited by 257
Self-citationAvdeef, A., Berger, C. M., & Brownell, C. (2000) · Pharmaceutical Research · doi:10.1023/a:1007526826979 · Cited by 260
Linear Correlation of the Fraction of Oral Dose Absorbed of 64 Drugs Between Humans and Rats
Chiou, W. L., & Barve, A. (1998) · Pharmaceutical Research · doi:10.1023/a:1011981317451 · Cited by 257
The effect of chronic renal failure on drug metabolism and transport
Dreisbach, A. W., & Lertora, J. J. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.8.1065 · Cited by 251
“Sun has proposed that the relative contribution of drug transport and metabolism to drug disposition can be predicted based on the physiochemical properties such as the drug solubility and permeability criteria of the Biopharmaceuticals Classification System (BCS) [10,32] .”
BackgroundFood macromolecule based nanodelivery systems for enhancing the bioavailability of polyphenols
Hu, B., Liu, X., Zhang, C., & Zeng, X. (2017) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2016.11.004 · Cited by 252
“[28] Amidon GL, Lennern€ as H, Shah VP, Crison JR.”
BackgroundFast Dissolving Curcumin Cocrystals
Sanphui, P., Goud, N. R., Khandavilli, U. B. R., & Nangia, A. (2011) · Crystal Growth & Design · doi:10.1021/cg200704s · Cited by 253
Pharmapolymers in the 21st century: Synthetic polymers in drug delivery applications
Englert, C., Brendel, J. C., Majdanski, T. C., Yildirim, T., Schubert, S., Gottschaldt, M., Windhab, N., & Schubert, U. S. (2018) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2018.07.005 · Cited by 247
Verreck, G., Six, K., Van den Mooter, G., Baert, L., Peeters, J., & Brewster, M. E. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00591-4 · Cited by 250
Varma, M. V. S., Kaushal, A. M., Garg, A., & Garg, S. (2004) · American Journal of Drug Delivery · doi:10.2165/00137696-200402010-00003 · Cited by 243
Clarke, H. D., Arora, K. K., Bass, H., Kavuru, P., Ong, T. T., Pujari, T., Wojtas, L., & Zaworotko, M. J. (2010) · Crystal Growth & Design · doi:10.1021/cg901345u · Cited by 248
Six, K., Verreck, G., Peeters, J., Brewster, M., & Mooter, G. V. D. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10522 · Cited by 246
Ezzat, K., EL Andaloussi, S., Zaghloul, E. M., Lehto, T., Lindberg, S., Moreno, P. M. D., Viola, J. R., Magdy, T., Abdo, R., Guterstam, P., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr072 · Cited by 236
Cole, E. T., Cadé, D., & Benameur, H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.009 · Cited by 241
Kirby, B. J., Symonds, W. T., Kearney, B. P., & Mathias, A. A. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0261-7 · Cited by 241
“6, and as such is a highsolubility and low-permeability, Biopharmaceutics Classification System Class 3 compound [4].”
BackgroundMeanwell, N. A. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00043 · Cited by 239
Self-emulsifying drug delivery systems: a novel approach to deliver drugs
Salawi, A. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2083724 · Cited by 212
“As per Biopharmaceutical Classification System (BCS), drugs are identified as class II (low solubility, high permeability) or class IV (low solubility, poor permeability).”
MethodBéduneau, A., Tempesta, C., Fimbel, S., Pellequer, Y., Jannin, V., Demarne, F., & Lamprecht, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.03.017 · Cited by 224
Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo
Linn, M., Collnot, E.-M., Djuric, D., Hempel, K., Fabian, E., Kolter, K., & Lehr, C.-M. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.11.025 · Cited by 242
“According to the biopharmaceutical classification system (BCS) the dissolution of poorly watersoluble drugs in gastrointestinal media is the limiting step for its permeation and absorption through the intestinal system (Amidon et al., 1995; Dressman and Reppas, 2000).”
BackgroundPotthast, H., Dressman, J. B., Junginger, H. E., Midha, K. K., Oeser, H., Shah, V. P., Vogelpoel, H., & Barends, D. M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20444 · Cited by 237
“The assignment of ibuprofen to BCS Class II is supported by an observed in vitroin vivo correlation (IVIVC) where a rank order was found between dissolution characteristics and the rate of absorption,(16) since IVIVC’s are predicted for BCS Class II drugs.(40) Other workers classified ibuprofen as BCS Class II also.”
MethodSelf-citationGonçalves, R. F. S., Martins, J. T., Duarte, C. M. M., Vicente, A. A., & Pinheiro, A. C. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.06.011 · Cited by 243
Metadata
- Authors
- Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R.
- Affiliations
- University of Michigan (US)
- Uppsala University (SE)
- United States Food and Drug Administration (US)
- Therapeutics Systems Research Laboratories (United States) (US)
- Venue
- Pharmaceutical Research
- Published
- 1995-03
- Volume
- 12
- Issue
- 3
- Pages
- 413-420
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1498305210
- Cited by
- 5,430
- References
- 29
- Citations by year
- 2026: 170 · 2025: 201 · 2024: 182 · 2023: 240 · 2022: 266 · 2021: 282 · 2020: 299 · 2019: 241 · 2018: 278 · 2017: 267 · 2016: 283 · 2015: 283 · 2014: 302 · 2013: 296 · 2012: 302
- FWCI
- 26.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Pharmaceutical Research (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Funders
- U.S. Food and Drug Administration (FD-01462)
- National Institute of General Medical Sciences (GM 37188, R01GM037188)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- in vitro-in vivo correlation, drug dissolution, bioavailability, gastrointestinal permeability, oral drug absorption, solubility, transport modeling, dissolution profile, surfactants
- MeSH terms
- Biological Availability, Cimetidine, Pharmaceutical Preparations, Gastric Emptying, Jejunum, Mathematics, Models, Theoretical, Permeability, Piroxicam, Solubility, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.